{"entity":{"type":"insider","cik":"0001706400","url":"/insider/0001706400","json_url":"/insider/0001706400.json","name":"Porter Derrell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2018-05-08","last":"2026-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Porter Derrell","source":"filing","n_filings":4,"first_seen":"2018-05-08","last_seen":"2026-06-17"}],"transactions":[{"id":5922085,"accession":"0001628280-26-043987","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-043987","line_url":"/filing/0001628280-26-043987#line-5","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13040.0,"shares_display":"13,040","price_per_share":2.325,"price_display":"2.32","price_state":"stated","total_value":30318.0,"total_display":"30,318.00","total_whole":"30,318","shares_owned_after":35500.0,"shares_owned_after_display":"35,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-17","scope":"insider"},{"id":5922081,"accession":"0001628280-26-043987","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-043987","line_url":"/filing/0001628280-26-043987#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12800.0,"shares_display":"12,800","price_per_share":2.326,"price_display":"2.33","price_state":"stated","total_value":29772.8,"total_display":"29,772.80","total_whole":"29,773","shares_owned_after":35500.0,"shares_owned_after_display":"35,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":5922077,"accession":"0001628280-26-043987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-043987","line_url":"/filing/0001628280-26-043987#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6460.0,"shares_display":"6,460","price_per_share":2.345,"price_display":"2.34","price_state":"stated","total_value":15148.7,"total_display":"15,148.70","total_whole":"15,149","shares_owned_after":48300.0,"shares_owned_after_display":"48,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":7945526,"accession":"0001209191-19-011175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011175","line_url":"/filing/0001209191-19-011175#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Officer (SVP, Head of Global Commercial)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Global Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Global Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5909.0,"shares_display":"5,909","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":236360.0,"total_display":"236,360.00","total_whole":"236,360","shares_owned_after":21688.0,"shares_owned_after_display":"21,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-19","scope":"insider"},{"id":6633223,"accession":"0001209191-18-030727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-030727","line_url":"/filing/0001209191-18-030727#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Officer (SVP, Head of Global Commercial)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Global Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Global Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16334.0,"shares_display":"16,334","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":735356.68,"total_display":"735,356.68","total_whole":"735,357","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":6235170,"accession":"0001209191-18-028714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-028714","line_url":"/filing/0001209191-18-028714#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001706400","owner_name":"Porter Derrell","owner_display_name":"Porter Derrell","owner_url":"/insider/0001706400","role":"Officer (SVP, Head of Global Commercial)","role_mark":"O","role_mark_label":"Officer (SVP, Head of Global Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Head of Global Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1544.0,"shares_display":"1,544","price_per_share":40.15,"price_display":"40.15","price_state":"stated","total_value":61991.6,"total_display":"61,991.60","total_whole":"61,992","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-08","filed_date":"2018-05-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576885","name":"Acumen Pharmaceuticals, Inc.","url":"/issuer/0001576885","role":"Director","n_filings":1,"first_seen":"2026-06-17","last_seen":"2026-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (SVP, Head of Global Commercial)","n_filings":3,"first_seen":"2018-05-08","last_seen":"2019-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706400","retrieved_at":"2026-08-24T16:59:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}